ASIA unversity:Item 310904400/112678
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 94286/110023 (86%)
造訪人次 : 21657498      線上人數 : 436
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋


    請使用永久網址來引用或連結此文件: http://asiair.asia.edu.tw/ir/handle/310904400/112678


    題名: The Different Cardiovascular Outcomes Between Long-Term Efficacy of Hydrophilic and Lipophilic Statin Therapy in Both Asian Diabetic Sexes.
    作者: Li, Shang-Yi;Li, Shang-Yi;Ch, Hsin-Hung;Chen, Hsin-Hung;Lin, Cheng-Li;Lin, Cheng-Li;Yeh, Su-Yin;Yeh, Su-Yin;高嘉鴻;Kao, Chia-Hung
    貢獻者: 生物資訊與醫學工程學系
    日期: 2019-09
    上傳時間: 2020-08-19 06:40:15 (UTC+0)
    出版者: 亞洲大學
    摘要: Purpose To evaluate the long-term efficacy of hydrophilic and lipophilic statin therapy for cardiovascular outcomes in Asian diabetic patients. Method Newly diagnosed cases of type 2 diabetes during the period from January 2000 to December 2011 were divided into 2 cohorts on the basis of their statin use, namely hydrophilic statin and lipophilic statin. We used Cox proportional hazard regression models to analyze the risks of cardiovascular outcomes. Result In this study, 12 896 patients used statin, including 4259 patients using hydrophilic statin and 8637 patients using lipophilic statin. With 12-year follow-up, higher incidence rate of coronary artery disease and stroke was noted in the lipophilic statin use instead of hydrophilic statin use. Conclusion According to our long-term cohort study, hydrophilic statin use may be a better choice than lipophilic statin to reduce cardiovascular events in Asian diabetic patients.
    關聯: Dose-Response
    顯示於類別:[生物資訊與醫學工程學系 ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    The_Different_Cardiovascular_Outcomes_Between_Long.pdf422KbAdobe PDF81檢視/開啟


    在ASIAIR中所有的資料項目都受到原著作權保護.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋